Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.71 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.65 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.65 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.65 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.53 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2532397 | 0.90 | LMNA (0.78) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| Hydrochloric Acid SCHEMBL28701756 | 0.87 | LMNA (0.75) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| SCHEMBL2533488 | 0.83 | TSHR (0.84) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| SCHEMBL451 | 0.83 | CYP3A4 (1.00) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| Lithium Ion SCHEMBL19462652 | 0.82 | LMNA (0.62) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| Potassium Ion SCHEMBL2096765 | 0.82 | LMNA (0.62) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| Pyridine SCHEMBL28418720 | 0.82 | CYP3A4 (0.88) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| Hydrochloric Acid SCHEMBL8898731 | 0.81 | CYP3A4 (0.95) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| Ammonia Solution, Strong SCHEMBL3848736 | 0.81 | CYP3A4 (0.95) | CYP3A4LMNAMAPTENPP2MKNK1 | |
| Bromide SCHEMBL1954236 | 0.81 | CYP3A4 (0.95) | CYP3A4LMNAMAPTENPP2MKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107987280-B | Aromatic cadmium sulfonate complex, preparation method and application thereof | 河南科技学院 | 2020-11-03 | — | — | CN | claimed |
| US-6288089-B1 | ADMINISTERING A COMPOSITION OF PYRIDYL IMIDAZOLE COMPOUNDS TO TREAT PARKINSON'S DISEASE, HUNTINGTON'S DISEASE, ALZHEIMER'S DISEASE, AND AMYOTOPHIC LATERAL SCLEROSIS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-09-11 | — | — | US | claimed |
| WO-1999009845-A1 | IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-04 | — | — | WO | claimed |
| WO-2024008116-A1 | HUMAN NASAL ORGANOIDS AND METHODS OF MAKING AND METHODS OF USE THEREOF | VERSITECH LIMITED (CN) | 2024-01-11 | — | — | WO | disclosed |
| CN-111936496-B | Heterocyclic compounds useful as medicaments | 马萨里克大学 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023030158-A1 | ALVEOLAR ORGANOIDS, METHODS OF MAKING AND USES THEREOF | VERSITECH LIMITED (CN) | 2023-03-09 | — | — | WO | disclosed |
| WO-2022078416-A1 | NOVEL GLUTAMINE ANALOGS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |
| EP-3775162-A1 | MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF | The University of Hong Kong (CN) | 2021-02-17 | — | — | EP | disclosed |
| CN-107987280-B | Aromatic cadmium sulfonate complex, preparation method and application thereof | 河南科技学院 | 2020-11-03 | — | — | CN | disclosed |
| CN-111712244-A | Compositions or methods for treating or preventing corneal endothelial disorders comprising (T) EW-7197 | 学校法人同志社 | 2020-09-25 | — | — | CN | disclosed |
| CN-110944668-A | Medicament comprising an mTOR inhibitor for treating or preventing ocular symptoms, disorders or diseases and uses thereof | 学校法人同志社 | 2020-03-31 | — | — | CN | disclosed |
| US-4833242-A | ANTIBIOTICS, BACTERICIDES | DAIICHI SEIYAKU CO., LTD. (JP) | 1989-05-23 | — | — | US | disclosed |
| US-4810800-A | HYPOTENSIVE AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-03-07 | — | — | US | disclosed |
| CN-87103323-A | The method for preparing new Dopamine HCL, hydroxylase inhibitors | — | 1988-02-03 | — | — | CN | disclosed |
| EP-0244803-A2 | Novel dopamine beta hydroxylase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1987-11-11 | — | — | EP | disclosed |
| EP-0159011-A2 | Cephalosporin derivatives, process for preparing them and pharmaceutical compositions containing them | DAIICHI SEIYAKU CO., LTD. (JP) | 1985-10-23 | — | — | EP | disclosed |
| US-4528195-A | Imidazole derivatives and salts thereof, their synthesis and intermediates and pharmaceutical formulations | THOROGOOD PETER B (GB) | 1985-07-09 | — | — | US | disclosed |
| EP-0003560-B1 | IMIDAZOLE DERIVATIVES AND SALTS THEREOF, THEIR SYNTHESIS, AND PHARMACEUTICAL FORMULATIONS | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-05-02 | — | — | EP | disclosed |
| US-4416895-A | ANTICOAGULANTS, ANTISHOCK AGENTS | BURROUGHS WELLCOME CO. (US) | 1983-11-22 | — | — | US | disclosed |
| EP-0003560-A2 | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-08-22 | — | — | EP | disclosed |